Article
Hereditary cancer genes are highly susceptible to splicing mutations.
PLoS genetics - 1 Mar 2018
Rhine Christy L, Cygan Kamil J, Soemedi Rachel, Maguire Samantha, Murray Michael F, Monaghan Sean F, Fairbrother William G
Abstract excerpt
Substitutions that disrupt pre-mRNA splicing are a common cause of genetic disease. On average, 13.4% of all hereditary disease alleles are classified as splicing mutations mapping to the canonical 5' and 3' splice sites. However, splicing mutations present in exons and deeper intronic positions are vastly underreported. A recent re-analysis of coding mutations in exon 10 of the Lynch Syndrome gene, MLH1,...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
